Frequency of Late Gadolinium Enhancement-Negative Cardiac Magnetic Resonance Imaging at Initial Presentation with Metabolically Active Treatment-Naïve Cardiac Sarcoidosis
The 2024 American Heart Association statement recommends fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) for patients with high clinical suspicion of cardiac sarcoidosis even without late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR), but this recommendation has been cha...